Skip to content
Gem Aromatics logo

Gem Aromatics

GEMAROMA NSE
₹139.96 +2.95 (+2.15%)
P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹139.96 −75.14 −34.9% 1Y
Start ₹215.10

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
3.43%
Debt to Equity
0.34
EPS (TTM)
−₹2.77
Book Value
₹83.25
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
1.68
ROE
0.39%
Dividend Yield
0.00%
EBITDA
₹41.60 Cr
52W High
₹228.00
52W Low
₹131.02
Day Range
₹137.28 – ₹143.18
Volume
68,715

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Gem Aromatics peer comparison
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
Gem Aromatics (this company)
₹139.96—₹718 Cr1.680.00%0.39%3.43%₹378 Cr−₹14 Cr
Median 8 companies₹1,559.5557.03₹20,474 Cr4.680.16%9.74%11.65%₹6,136 Cr₹692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

31 Poor

Data confidence 91/100

Category scores

Quality
41
Weak
Returns, margins, earnings quality 22% weight
Valuation
23
Poor
Cheap vs sector & own history 24% weight
Growth
3
Poor
Sales & profit trajectory 9% weight
Financial Health
40
Weak
Solvency, leverage, coverage 9% weight
Momentum
18
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 3.68% over past five years.
  • Company has a low return on equity of 12.6% over last 3 years.
  • Company might be capitalizing the interest cost

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1054
OscillatorsNeutral252
Moving AveragesStrong Bearish802

Key readings

RSI (14)
41.25
Neutral
MACD (12,26,9)
−4.86
Bullish
SMA (50)
153.49
Bearish
SMA (200)
169.03
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+3.65%
3Y−4.86%
1Y−27.38%
TTM−24.30%

Net profit

Net profit growth by window
5Y−46.59%
3Y−71.89%
1Y−98.11%
TTMTurned to loss

Operating cash flow

Operating cash flow growth by window
5YZero base
3Y+25.99%
1YTurned positive
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y+1.07 pp
3Y−4.33 pp
1Y−6.26 pp
TTM−10.16 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹306 Cr
Mar 2022₹314 Cr
Mar 2023₹425 Cr
Mar 2024₹452 Cr
Mar 2025₹504 Cr
Mar 2026₹366 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021₹23.00 Cr
Mar 2022₹31.00 Cr
Mar 2023₹45.00 Cr
Mar 2024₹50.00 Cr
Mar 2025₹53.00 Cr
Mar 2026₹1.00 Cr

Quarterly Results

₹ Cr
GEMAROMA quarterly results, ₹ crore
Particulars Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
92.67
112
96.84
202
87.63
89.53
78.9
110
98.85
104
Expenses
78.46
96.87
83.81
156
72.77
86.48
71.88
94.7
95.55
96.13
Operating Profit
14.21
15.35
13.03
45.87
14.86
3.05
7.02
15.71
3.3
7.87
OPM %
15.33%
13.68%
13.46%
22.68%
16.96%
3.41%
8.9%
14.23%
3.34%
7.57%
Other Income
0.89
0.73
0.5
−0.43
1.27
0.98
−1.66
0.3
0.16
0.13
Interest
1.1
1.33
2.22
3.44
3.52
3.5
2.58
2.97
2.88
4.74
Depreciation
1.69
1.84
1.89
1.92
1.82
3.05
8.71
9.01
9.13
9.53
PBT
12.31
12.91
9.42
40.08
10.79
−2.52
−5.93
4.03
−8.54
−6.28
Tax %
30.3%
24.63%
20.81%
31.11%
25.95%
2.38%
−15.85%
74.94%
−7.84%
11.78%
Net Profit
8.59
9.74
7.46
27.6
7.98
−2.58
−4.99
1.01
−7.87
−7.02
EPS (₹)
1.83
2.08
1.59
5.89
1.7
−0.49
−0.96
0.19
−1.51
—

Sep 2026: from the results filed on 31 Oct 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
GEMAROMA profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
306
314
425
452
504
366
378
Expenses
275
265
359
374
415
326
349
Operating Profit
31
49
66
78
88
41
29
OPM %
10%
16%
16%
17%
18%
11%
8%
Other Income
4
3
0
2
1
1
0
Interest
2
3
6
6
8
13
12
Depreciation
3
4
5
6
7
23
30
PBT
30
44
56
68
74
6
−13
Tax %
23%
30%
20%
26%
28%
78%
—
Net Profit
23
31
45
50
53
1
−14
EPS (₹)
130
175
250
10.69
11.39
0.27
−2.77
Div. Payout %
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
GEMAROMA balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
2
2
9
9
10
Reserves
108
136
178
221
275
439
Borrowings
55
78
90
112
227
152
Other Liabilities
20
23
26
26
26
40
Total Liabilities
186
240
296
369
536
642
Fixed Assets
24
36
36
50
54
253
CWIP
2
1
11
30
126
6
Investments
0
0
0
0
0
0
Other Assets
160
203
249
289
356
382
Total Assets
186
240
296
369
536
642

Cash Flow

₹ Cr
GEMAROMA cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
−5
15
40
−25
30
Investing
−5
−15
−18
−50
−92
−102
Financing
7
18
6
15
105
78
Net Cash Flow
2
−2
4
5
−13
5
Free Cash Flow
−6
−19
1
1
−130
−65
CFO/OP
24
12
50
71
0
100

Ratios

GEMAROMA financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
63
46
68
37
102
76
Inventory Days
120
206
164
187
160
309
Days Payable
23
27
24
20
16
25
Cash Conversion Cycle
160
225
208
203
246
360
Working Capital Days
90
110
102
121
115
179
ROCE %
—
25%
25%
24%
19%
3%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gem Aromatics insights

47 extracted metrics across FY21–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 57.45%
  • Others 20.79%
  • Public 16.41%
  • DIIs 4.95%
  • FIIs 0.39%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Gem Aromatics

What does Gem Aromatics Ltd do?
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India.
Where is Gem Aromatics Ltd (GEMAROMA) listed?
Gem Aromatics Ltd trades as GEMAROMA on the NSE and under code 544491 on the BSE.
Which sector does Gem Aromatics Ltd belong to?
Gem Aromatics Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the 52-week high and low of Gem Aromatics Ltd?
Over the last 52 weeks Gem Aromatics Ltd has traded between ₹131.02 and ₹228 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Gem Aromatics Ltd?
Gem Aromatics Ltd reported a return on equity of 0.39%. Its debt-to-equity ratio is 0.34.

Company Information

Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India.

CEO Ms. Kaksha Vipul Parekh
Listed 26 Aug 2025
Face Value ₹2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GEMAROMA.md for Gem Aromatics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More